zepbound news - Search News

FDA, Zepbound and obstructive sleep apnea

Hosted on MSN · 10h

The FDA says the shortage of popular weight loss drug Zepbound is over. Here's what that means for patients.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

People on MSN · 1h

FDA Approves Weight Loss Medication Zepbound to Treat Sleep Apnea

The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity.” In addition to the GLP-1 prescription, the FDA suggests that users reduce their calorie intake and increase their exercise.

FDA approves Zepbound for obstructive sleep apnea

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep apnea.

20hon MSN

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

1don MSN

Harvey Fierstein Lost 120 lbs. on Zepbound: 'Being Fat Is Not a Choice'

The Broadway icon said he’s a “great believer” in the weight-loss medication, which helped him after he weighed 310 lbs.

21hOpinion

We've Accepted Wegovy and Zepbound. The Next Phase Is Harder.

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results